Fezagepras (PBI-4050) A Free Fatty Acid Mimetic for the Treatment of NAFLD

March 5, 2020

No Previous Flipbooks

Next Flipbook
Fezagepras (PBI-4050) Reduces Pulmonary Fibroblast Activation
Fezagepras (PBI-4050) Reduces Pulmonary Fibroblast Activation